Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Baylor Genetics | RCV000785780 | SCV003835829 | likely pathogenic | Encephalopathy, acute, infection-induced, susceptibility to, 9 | 2022-12-11 | criteria provided, single submitter | clinical testing | |
| Victorian Clinical Genetics Services, |
RCV000785780 | SCV003921932 | pathogenic | Encephalopathy, acute, infection-induced, susceptibility to, 9 | 2022-06-24 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with susceptibility to infection-induced acute encephalopathy (MIM#618426). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to cysteine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 18 heterozygotes, 0 homozygotes). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. It has been reported in a family with two affecteds who presented with encephalopathy and developmental regression after a febrile illness (PMID: 31178128). (SP) 0902 - This variant has moderate evidence for segregation with disease. Two affecteds, the proband and his cousin, were reported from a large consanguineous family (PMID: 31178128). (SP) 1001 - This variant has strong functional evidence supporting abnormal protein function. Using patient's fibroblasts, both reduced protein expression and dysfunctional nuclear transport were demonstrated (PMID: 31178128). (SP) 1102 - Strong phenotype match for this individual. (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
| Hadassah Hebrew University Medical Center | RCV000714270 | SCV000746232 | likely pathogenic | Progressive microcephaly; Recurrent encephalopathy | no assertion criteria provided | research | ||
| OMIM | RCV000785780 | SCV000924345 | risk factor | Encephalopathy, acute, infection-induced, susceptibility to, 9 | 2019-06-19 | no assertion criteria provided | literature only |